Takeda Will Pay Up To $2.4B To Resolve Actos Suits
Takeda Pharmaceutical Co. Ltd. has agreed to pay up to $2.4 billion to resolve the "vast majority" of product liability suits over its diabetes drug Actos, which plaintiffs have claimed can...To view the full article, register now.
Already a subscriber? Click here to view full article